Dr. Jacobs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Pathology-Anatomic and Clinical, 1979 - 1981
University of the WitwatersrandClass of 1971
Certifications & Licensure
OH State Medical License 1981 - 2026
Publications & Presentations
PubMed
- ARGONAUT-IV: susceptibility of carbapenemase-producingto the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibuten.Michael R Jacobs, Caryn E Good, Ayman M Abdelhamed, Andrew R Mack, Christopher R Bethel
Antimicrobial Agents and Chemotherapy. 2024-12-05 - A molecular analysis of meropenem-vaborbactam non-susceptible KPC-producing.Mohamad Yasmin, Steven H Marshall, Liang Chen, Daniel D Rhoads, Michael R Jacobs
Antimicrobial Agents and Chemotherapy. 2024-10-08 - 1 citationsARGONAUT-III and -V: susceptibility of carbapenem-resistantand multidrug-resistantto the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime.Michael R Jacobs, Ayman M Abdelhamed, Caryn E Good, Andrew R Mack, Christopher R Bethel
Antimicrobial Agents and Chemotherapy. 2024-09-04
Lectures
- Drug Resistance to Antibiotics Continues To Spread46th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, California, US
- Drug Resistance to Antibiotics Continues To SpreadAmerican Society for Microbiology, 46th Interscience Conference on Antimicrobial Agents and Chemothe
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
